Sildenafil Citrate Market Size & Share, by Use (Medical and Non- Medical); Distribution Channel (Online and Offline); End User (Adults - Male, Medical Researchers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037

Growth Drivers

• Prevalence of Erectile Dysfunction: It is estimated that ageing in men increases the risk of erectile dysfunction in them. However it is stated that ED can occur at any age, but most common in older men. ED can be also be caused by heart-related diseases, diabetes, obesity, tobacco and alcohol consumption. According to the WHO, the proportion of world’s population over 60 years is estimated to nearly double from 12% to 22% between 2015 and 2020. Further, it was reported by IHME, that in 2017, 4.7 million deaths globally were caused by obesity and majority of the cases were reported in urban areas of the world where reduced activity and poor diets are attributed to accelerate the rise of it. Ageing population, prevalence of cardiovascular diseases, obesity and high consumption of alcohol and tobacco are factors contributing to increase in the number of ED cases and thus expected to positively impact the sildenafil citrate market.
• Awareness towards ED by Governments and NGOs: Adult males shy away from the topic of ED in public discussions. Understanding and acceptance about ED and its prevalence among adult males through awareness programs by governments and NGOs is expected to drive the sildenafil citrate market forward.

Challenges

• Availability of Erectile Dysfunction Alternatives: The availability of alternatives such as Tadalafil (Cialis), Vardenafil (Levitra) and Vardenafil (Staxyn) is expected to negatively impact the sales of sildenafil citrate medication and thus hamper the sildenafil citrate market growth in the coming years.